Denis Patrick is listed as a director on 4 SEC Form D filings by 1 issuer between Jan 2020 and Nov 2024: EvolveImmune Therapeutics Holding Company, LLC (Branford, CT — biotechnology — 2020–2024; $37.4M reported sold to 9 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Stephen Bloch (4 shared filings), Alessandra Di Bacco (3 shared filings), Derek Yoon (3 shared filings), Ian Taylor (3 shared filings), Donmienne Leung (1 shared filing) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Denis. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Denis Patrick and found 5 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Denis Patrick" (MA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.